Transplantation for Viral Hepatitis A and B

Transplantation of the Liver

Volumn , Issue , 2005, Pages 115-128

  Roche, Bruno ^a   Samuel, Didier ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646582872     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50013-6     Document Type: Chapter

References (86)

1. EC Seaberg, SH Belle, KC Beringer, et al. (1999) Liver transplantation in the United States from 1987–1998: Updated results from the Pitt-UNOS liver transplant registry. JM Cecka, PI Terasaki (Eds) Clinical Transplants 1998 Los Angeles: UCLA Tissue Typing Laboratory 17-37.
2. European Liver Transplant Registry (ELTR)—Registry for the European liver transplant association, data analysis, 05/1968–6/2002, online: Available at http://www-eltr.org
3. S Todo, AJ Demetris, D Van Thiel, et al. (1991) Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 13 619-626.
4. JG O'Grady, HM Smith, SE Davies, et al. (1992) Hepatitis B virus re-infection after orthotopic liver transplantation: Serological and clinical implications. J Hepatol 14 104-111.
5. T Steinmuller, D Seehofer, N Rayes, et al. (2002) Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 35 1528-1535.
6. D Shouval and D Samuel (2000) Hepatitis B immune globulin to prevent HBV graft reinfection following liver transplantation: A concise review. Hepatology 32 1189-1195.
7. MG Ghany, B Ayola, FG Villamil, et al. (1998) Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27 213-222.
8. NA Terrault, S Zhiou, RW McCory, et al. (1998) Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 28 555-561.
9. A Brind, JJ Jiang, D Samuel, et al. (1997) Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 26 228-235.
10. CM Lo, JTK Fung, GKK Lau, et al. (2003) Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology 37 36-43.
11. D Samuel, R Muller, G Alexander, et al. (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329 1842-1847.
12. D Samuel, A Bismuth, D Mathieu, et al. (1991) Passive immunoprophy-laxis after liver transplantation in HBsAg-positive patients. Lancet 337 813-815.
13. W Lauchart, R Muller and R Pichlmayr (1987) Long-term immunoprophy-laxis of hepatitis B virus (HBV) re-infection in recipients of human liver allografts. Transplant Proc 19 4051-4053.
14. B Roche, C Feray, M Gigou, et al. (2003) HBV DNA persistence 10 years after liver transplantation despite successful anti-HBs immunoprophylaxis. Hepatology 38 86-95.
15. NA Terrault, S Zhou, C Combs, et al. (1996) Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulins. Hepatology 24 1327-1333.
16. R Muller, G Gubernatis, M Farle, et al. (1991) Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunisation. J Hepatol 13 90-96.
17. RW McGory, MB Ishitani, WM Oliveira, et al. (1996) Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 61 1358-1364.
18. J Gugenheim, F Crafa, P Fabiani, et al. (1992) Récidive du virus de l'hépatite B aprés transplantation hépatique. Gastroenterol Clin Biol 16 430-433.
19. RG Sawyer, RW McGory, MJ Gaffey, et al. (1998) Improved clinical outcome with liver transplantation for hepatitis B related cirrhosis. Ann Surg 227 841-850.
20. JA Lowell, S Burgess, S Shenoy, et al. (1996) Mercury poisoning associated with high dose hepatitis B immune globulin administration after liver transplantation. Liver Transpl Surg 2 475-478.
21. RA DeMan, P Marcellin, F Habal, et al. (2000) A randomized placebocontrolled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B. Hepatology 32 413-417.
22. JP Villeneuve, LD Condreay, B Willems, et al. (2000) Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 31 207-210.
23. D Kapoor, RC Guptan, SM Wakil, et al. (2000) Beneficial effects of lamivudine in hepatitis B virus–related decompensated cirrhosis. J Hepatol 33 308-312.
24. RP Perrillo, T Wright, J Rakela, et al. (2001) A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after transplantation for chronic hepatitis B. Hepatology 33 424-432.
25. FY Yao, NA Terrault, C Freise, et al. (2001) Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology 34 411-416.
26. R Fontana, E Keeffe, W Carey, et al. (2002) Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl 8 433-439.
27. R Fontana, H Hann, R Perrillo, et al. (2002) Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology 123 719-727.
28. R Perrillo, E Schiff, E Yoshida, et al. (2000) Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32 129-134.
29. E Schiff, CL Lai, P Neuhaus, et al. (2002) Adefovir dipivoxil for the treatment of chronic hepatitis B in patients pre- and post-liver transplantation with lamivudine-resistant hepatitis B virus. Hepatology 36 371A.
30. P Stärkel, Y Horsmans, A Geubel, et al. (2001) Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to emergence of a hepatitis B YMDD escape mutant virus. J Hepatol 35 679-681.
31. S Saab, M Kim, T Wright, et al. (2000) Successful orthotopic liver transplantation for lamivudine associated YMDD mutant hepatitis B virus. Gastroenterology 119 1382-1384.
32. J Rosenau, M Bahr, HL Tillmann, et al. (2001) Lamivudine and lowdose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation: Possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J Hepatol 34 895-902.
33. L Grellier, D Mutimer, M Ahmed, et al. (1996) Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 348 1212-1215.
34. D Mutimer, G Dusheiko, C Barrett, et al. (2000) Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up. Transplantation 70 809-815.
35. CM Lo, ST Cheung, CL Lai, et al. (2001) Liver transplantation in Asian patients with chronic hepatitis B using Lamivudine prophylaxis. Ann Surg 233 276-281.
36. G Malkan, M Cattral, A Humar, et al. (2000) Lamivudine for hepatitis B in liver transplantation. Transplantation 69 1403-1407.
37. JS Markowitz, P Martin, AJ Conrad, et al. (1998) Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 28 585-589.
38. A Marzano, M Salizzoni, W Debernardi-Venon, et al. (2001) Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immuno-prophylaxis. J Hepatol 34 903-910.
39. PW Angus, GW McCaughan, EJ Gane, et al. (2000) Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl 6 429-433.
40. FY Yao, RW Osorio, JP Roberts, et al. (1999) Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl Surg 5 491-496.
41. EM Yoshida, SR Erb, N Partovi, et al. (1999) Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin. Liver Transpl Surg 5 520-525.
42. GW McCaughan, J Spencer, D Koorey, et al. (1999) Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. Liver Transpl Surg 6 512-519.
43. SH Han, J Ofman, C Holt, et al. (2001) An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl 6 741-748.
44. D Seehofer, N Rayes, U Naumann, et al. (2001) Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation 72 1381-1385.
45. EJ Gane, G McCaughan, D Crawford, et al. (2002) Combination lamivudine plus low dose intramuscular hepatitis B immunoglobulin prevents recurrent hepatitis B and may eradicate residual graft infection. Hepatology 36 221A.
46. B Roche, D Samuel, AM Roque, et al. (1999) Intravenous anti-HBs Ig combined with oral lamivudine for prophylaxis against HBV recurrence after liver transplantation (abstract). J Hepatol 30 A80.
47. SH Han, P Martin, M Edelstein, et al. (2003) Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl 9 182-187.
48. A Sanchez-Fueyo, A Rimola, L Grande, et al. (2000) Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 31 496-501.
49. A Sanchez-Fueyo, E Martinez-Bauer and A Rimola (2002) Hepatitis B vaccination after liver transplantation. Hepatology 36 257-258.
50. U Bienzle, M Gunther, R Neuhaus, et al. (2002) Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: Preliminary results. Live Transpl 8 562-564.
51. M Angelico, D Di Paolo, M Trinito, et al. (2002) Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 35 176-181.
52. SF Dodson, ME De Vera, CA Bonham, et al. (2000) Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl 6 434-439.
53. NV Naoumov, AR Lopes, P Burra, et al. (2001) Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol 34 888-894.
54. M Buti, A Mas, M Prieto, et al. (2003) A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation. J Hepatol 38 811-817.
55. MJ Phillips, R Cameron, MA Flowers, et al. (1992) Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steato-viral, and fibroviral hepatitis. Am J Pathol 140 1295-1308.
56. SE Davies, BC Portmann, JG O'Grady, et al. (1991) Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13 150-157.
57. R Tur-Kaspa and O Laub (1990) Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 11 34-36.
58. RG Gish, EB Keefe, J Lim, et al. (1995) Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. J Hepatol 22 257-262.
59. NA Terrault, C Combs Holland, L Ferrel, et al. (1996) Interferon alpha for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg 2 132-138.
60. RG Gish, JYN Lau, L Brooks, et al. (1996) Ganciclovir treatment of hepatitis B virus (HBV) infection in liver transplant patients. Hepatology 23 1-7.
61. B Roche, D Samuel, M Gigou, et al. (1999) Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. J Hepatol 31 584-592.
62. N Rayes, D Seehofer, U Hopf, et al. (2001) Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. Transplantation 71 96-101.
63. R Perrillo, J Rakela, J Dienstag, et al. (1999) Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Hepatology 29 1581-1586.
64. B Roche, D Samuel, AM Roque, et al. (1999) Lamivudine therapy for HBV infection after liver transplantation (abstract). J Hepatol 30 78.
65. RJ Fontana, HW Hann, T Wright, et al. (2001) A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transpl 6 504-510.
66. K Chayama, Y Suzuki, M Kobayashi, et al. (1998) Emergence and takeover of YMDD motif mutant hepatitis B virus during longterm lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27 1711-1716.
67. CT Bock, HL Tillmann, J Torresi, et al. (2002) Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 22 264-273.
68. R Perrillo, E Schiff, E Yoshida, et al. (2000) Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32 129-134.
69. Y Benhamou, M Bochet, V Thibault, et al. (2001) Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: An open-label pilot study. Lancet 358 718-723.
70. MG Peters, G Singer, T Howard, et al. (1999) Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: Durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 68 1912-1914.
71. D Mutimer, BH Feraz-Neto, R Harrison, et al. (2001) Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: Rapid resolution during treatment with adefovir. Gut 49 860-863.
72. KM Walsh, T Woodall, P Lamy, et al. (2001) Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus. Gut 49 436-440.
73. H Yang, CE Westland, WE Delaney, et al. (2002) Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks. Hepatology 36 464-473.
74. AO Shakil, L Lilly, P Angus, et al. (2001) Entecavir reduces viral load in liver transplant patients who have failed prophylaxis or treatment for hepatitis B (abstract). Hepatology 34(suppl), 619.
75. F Van Bommel, T Wunsche, D Schurmann, et al. (2002) Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication. Hepatology 36 507-508.
76. J Crippin, B Foster, S Carlen, et al. (1994) Retransplantation in hepatitis B—a multicenter experience. Transplantation 57 823-826.
77. B Roche, D Samuel, C Feray, et al. (1999) Retransplantation of the liver for recurrent hepatitis B virus infection: The Paul Brousse experience. Liver Transpl Surg 5 166-174.
78. A Ottobrelli, A Marzano, A Smedile, et al. (1991) Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 101 1649-1655.
79. D Samuel, AL Zignego, M Reynes, et al. (1995) Long-term clinical and virologic outcome after liver transplantation for cirrhosis due to chronic delta hepatitis. Hepatology 21 333-339.
80. H Bismuth, D Samuel, J Gugenheim, et al. (1987) Emergency Liver transplantation for fulminant hepatitis. Ann Intern Med 107 337-341.
81. SM Lemon and CN Shapiro (1994) The value of immunization against hepatitis A. Infect Agents Dis 3 38-49.
82. G Rezende, AM Roque-Afonso, D Samuel, et al. (2003) Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 38 613-618.
83. G Ostapowicz, RJ Fontana, FV Schiodt, et al. (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 947-954.
84. MP Chenard-Neu, K Boudjema, J Bernuau, et al. (1996) Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure: A multicenter European Study. Hepatology 23 1119-1127.
85. H Bismuth, D Azoulay, D Samuel, et al. (1996) Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience. Ann Surg 224 712-724.
86. D Azoulay, D Samuel, P Ichai, et al. (2001) Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure. Ann Surg 234 723-731.